• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌肝转移切除术的预后指标。

Prognostic indicator for the resection of liver metastasis of colorectal cancer.

作者信息

Amano Ryosuke, Yamada Nobuya, Nakata Bunzo, Kimura Kenjiro, Yashiro Masakazu, Ohira Masaichi, Hirakawa Kosei

机构信息

Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan,

出版信息

Surg Today. 2014 Jul;44(7):1287-92. doi: 10.1007/s00595-013-0699-x. Epub 2013 Aug 27.

DOI:10.1007/s00595-013-0699-x
PMID:23979110
Abstract

PURPOSE

We investigated the predictive indicator for a good prognosis of surgical resection for liver metastasis of colorectal cancer.

METHOD

Between 1990 and 2009 at our institute, 117 patients underwent 132 hepatic resections for liver metastasis of colorectal cancer. The clinical, pathological, and outcome parameters affecting their prognoses were analyzed. The extent of the liver metastases was subdivided according to the Japanese Classification of Colorectal Carcinoma (JCCRC), and the patients were classified into different grades based on the JCCRC classification and the status of the nodal involvement of the primary tumor.

RESULT

The median survival time (MST) of the 117 patients was 58 months, and the actuarial survival rates at 1, 3, and 5 years were 92.3, 60.0, and 46.1 %, respectively. A multivariate analysis revealed that the JCCRC Grade classification was an independent prognostic indicator (Grade A vs. B vs. C: MST, 72 vs. 41 vs. 23 months; 5-year survival, 59.0 vs. 38.6 vs. 0 %: p < 0.0001).

CONCLUSION

Our findings indicate that the JCCRC Grade classification for liver metastasis of colorectal cancer is a significant prognostic indicator and may be useful for making decisions regarding the treatment of liver metastasis.

摘要

目的

我们研究了结直肠癌肝转移手术切除预后良好的预测指标。

方法

1990年至2009年期间,我院117例患者因结直肠癌肝转移接受了132次肝切除术。分析了影响其预后的临床、病理和结局参数。根据日本结直肠癌分类(JCCRC)对肝转移范围进行细分,并根据JCCRC分类和原发肿瘤的淋巴结受累情况将患者分为不同等级。

结果

117例患者的中位生存时间(MST)为58个月,1年、3年和5年的精算生存率分别为92.3%、60.0%和46.1%。多因素分析显示,JCCRC分级分类是一个独立的预后指标(A级与B级与C级:MST,72个月对41个月对23个月;5年生存率,59.0%对38.6%对0%:p<0.0001)。

结论

我们的研究结果表明,结直肠癌肝转移的JCCRC分级分类是一个重要的预后指标,可能有助于做出关于肝转移治疗的决策。

相似文献

1
Prognostic indicator for the resection of liver metastasis of colorectal cancer.结直肠癌肝转移切除术的预后指标。
Surg Today. 2014 Jul;44(7):1287-92. doi: 10.1007/s00595-013-0699-x. Epub 2013 Aug 27.
2
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].[结直肠癌肝转移肝切除术后长期预后的预后因素]
Chir Ital. 2005 Sep-Oct;57(5):555-70.
3
Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.伴有肝中央型转移的结直肠癌肝切除术的临床特征及预后
World J Surg Oncol. 2015 Mar 4;13:92. doi: 10.1186/s12957-015-0497-6.
4
Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.结直肠癌肝转移的治疗结果:特别提及肝切除术的有效性——对18家机构记录的763例病例的预后因素分析
Dis Colon Rectum. 2003 Oct;46(10 Suppl):S22-31. doi: 10.1097/01.DCR.0000089106.71914.00.
5
Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma.结直肠癌肝转移肝切除术后长期生存的术前预后因素分析
J Gastrointest Surg. 2005 Mar;9(3):374-80. doi: 10.1016/j.gassur.2004.09.031.
6
Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.术前化疗时代结直肠肝转移切除术后的预后因素和生存:一项 11 年单中心研究。
Dig Surg. 2013;30(4-6):293-301. doi: 10.1159/000354310. Epub 2013 Aug 21.
7
Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.评估肝转移结直肠癌患者的治疗效果及治疗安全性,并对预后因素进行评估。
Pol Przegl Chir. 2013 Jun;85(6):333-9. doi: 10.2478/pjs-2013-0050.
8
Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.初始切除的结直肠癌肝转移患者复发时间、治疗及复发后生存的预测因素
World J Surg Oncol. 2015 Dec 3;13:328. doi: 10.1186/s12957-015-0738-8.
9
Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.结直肠癌肝转移肝切除术后复发的预测因素分析。
World J Surg. 2001 Sep;25(9):1129-33. doi: 10.1007/BF03215859.
10
Extended resections of liver metastases from colorectal cancer.结直肠癌肝转移灶的扩大切除术
World J Surg. 2007 Mar;31(3):511-21. doi: 10.1007/s00268-006-0140-3.

引用本文的文献

1
Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy.转移性结直肠癌转移相关免疫预后模型的建立及其在免疫治疗中的应用
Front Cell Dev Biol. 2021 Jan 28;8:577125. doi: 10.3389/fcell.2020.577125. eCollection 2020.
2
SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis.SP1 诱导的长链非编码 RNA-ZFAS1 通过 miR-150-5p/VEGFA 轴促进结直肠癌的进展。
Cell Death Dis. 2018 Sep 24;9(10):982. doi: 10.1038/s41419-018-0962-6.
3
Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study.

本文引用的文献

1
The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma.预后营养指数可作为结直肠癌的预后指标。
Surg Today. 2012 Jun;42(6):532-5. doi: 10.1007/s00595-011-0061-0. Epub 2011 Dec 3.
2
Different incidence of synchronous liver metastasis between proximal and distal colon cancer.近端结肠癌和远端结肠癌的同步肝转移发生率不同。
Surg Today. 2012 May;42(5):426-30. doi: 10.1007/s00595-011-0056-x. Epub 2011 Nov 18.
3
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
结直肠癌孤立性肝转移切除术后预后因素分析:一项为期22年的双中心研究
J Cancer Res Clin Oncol. 2018 Mar;144(3):593-599. doi: 10.1007/s00432-018-2583-y. Epub 2018 Jan 16.
4
Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.使用下一代测序技术对有和没有肝转移的原发性结直肠癌患者的癌组织进行转录组分析。
Cancer Med. 2017 Aug;6(8):1976-1987. doi: 10.1002/cam4.1147. Epub 2017 Jul 26.
5
Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review.原发性肝血管肉瘤转移至结肠:一例报告及文献综述
Oncol Lett. 2017 Apr;13(4):2765-2769. doi: 10.3892/ol.2017.5755. Epub 2017 Feb 21.
6
Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases.结直肠癌肝转移患者中基于转移结节数量的预后因素
Ann Coloproctol. 2016 Jun;32(3):92-100. doi: 10.3393/ac.2016.32.3.92. Epub 2016 Jun 30.
7
Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.微小RNA-132的下调与结直肠癌的不良预后相关。
Ann Surg Oncol. 2016 Dec;23(Suppl 5):599-608. doi: 10.1245/s10434-016-5133-3. Epub 2016 Feb 11.
8
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.血清中的外泌体微小RNA是人类结直肠癌复发的一种新型生物标志物。
Br J Cancer. 2015 Jul 14;113(2):275-81. doi: 10.1038/bjc.2015.201. Epub 2015 Jun 9.
9
Is intraoperative ultrasound still useful for the detection of colorectal cancer liver metastases?术中超声对结直肠癌肝转移的检测仍有用吗?
HPB (Oxford). 2015 Jun;17(6):514-9. doi: 10.1111/hpb.12393. Epub 2015 Feb 28.
10
Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy.对化疗难治的不可切除的以肝脏为主的结直肠癌进行选择性经动脉放射性栓塞治疗。
Radiol Med. 2015 Aug;120(8):767-76. doi: 10.1007/s11547-015-0504-6. Epub 2015 Feb 13.
预测接受肝切除术治疗结直肠肝转移患者无病生存的列线图:日本肝胆胰外科学会肝脏外科研讨会项目的多中心数据收集。
J Hepatobiliary Pancreat Sci. 2012 Jan;19(1):72-84. doi: 10.1007/s00534-011-0460-z.
4
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.一项比较氟尿嘧啶/亚叶酸辅助治疗与 FOLFIRI 在结直肠癌肝转移完全切除术后患者中的随机 III 期研究。
Ann Oncol. 2009 Dec;20(12):1964-70. doi: 10.1093/annonc/mdp236. Epub 2009 Jun 30.
5
Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?对于伴有淋巴结转移的结直肠癌肝转移患者,化疗后进行肝切除是否合理?
J Clin Oncol. 2008 Aug 1;26(22):3672-80. doi: 10.1200/JCO.2007.15.7297.
6
Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis.手术技术和全身炎症影响结直肠癌肝转移切除术后的长期无病生存。
J Surg Oncol. 2008 Oct 1;98(5):371-6. doi: 10.1002/jso.21103.
7
Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin.结直肠癌肝转移患者肝外疾病同期切除的预后价值
Surgery. 2008 Jun;143(6):706-14. doi: 10.1016/j.surg.2008.02.004. Epub 2008 Apr 11.
8
A new classification system for liver metastases from colorectal cancer in Japanese multicenter analysis.日本多中心分析中结直肠癌肝转移的新分类系统
Hepatogastroenterology. 2008 Jan-Feb;55(81):173-8.
9
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.贝伐单抗联合奥沙利铂为基础的化疗作为转移性结直肠癌的一线治疗:一项随机III期研究。
J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930.
10
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.FOLFOX4围手术期化疗联合手术与单纯手术治疗可切除的结直肠癌肝转移(欧洲癌症研究与治疗组织(EORTC)国际协作组试验40983):一项随机对照试验
Lancet. 2008 Mar 22;371(9617):1007-16. doi: 10.1016/S0140-6736(08)60455-9.